Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers

Erika Murce, Erik de Blois, Sophie van den Berg, Marion de Jong, Yann Seimbille*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

6 Downloads (Pure)


Targeted radionuclide therapy (TRT) is a promising strategy to treat different types of cancer. TRT relies on a targeting vector used to deliver a therapeutic radionuclide specifically to the tumour site. Several low molecular weight ligands targeting the prostate-specific membrane antigen (PSMA) have been synthesized, but their pharmacokinetic properties still need to be optimized. Hereby, we describe the synthesis of new conjugates, featuring the cleavable linkers Gly-Tyr-Lys (GYK) and Met-Val-Lys (MVK), to reduce the dose delivered to the kidneys. Compounds were synthesized by solid-phase peptide synthesis (SPPS) and obtained in greater than 95% chemical purity. Radiolabelling was performed with both In-111 and Lu-177 to validate potential use of the compounds as both imaging and therapeutic agents. Radiochemical purity greater than 80% was obtained for both nuclides, but significant radiolysis was observed for the methionine-containing analogue. The results obtained thus far with the GYK-PSMA conjugate could warrant further biological investigations.

Original languageEnglish
Article number220950
JournalRoyal Society Open Science
Issue number3
Publication statusPublished - 8 Mar 2023

Bibliographical note

Publisher Copyright:
© 2023 The Authors.


Dive into the research topics of 'Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers'. Together they form a unique fingerprint.

Cite this